CCR4 and neoplasm: Humanized mice have been utilized in OC: a model developed with CAR-T cells demonstrated complete tumor regression [57], and monoclonal antibody immunotherapy in a separate model showed that anti-CCR4 enhanced the anti-tumor immune response by hindering the infiltration of Tregs into the TME [58].